Cargando…

The Immunogenicity and Safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis Vaccine Given with a Two-dose Primary Schedule in Children

Effective and tolerable vaccination is an essential strategy to prevent Japanese encephalitis (JE) in endemic areas. Although the live attenuated SA 14-14-2 JE vaccine (LAJEV) has been widely used since its introduction, the systemic data of LAJEV was very rarely available in Korea. We conducted the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwon, Hyo Jin, Lee, Soo Young, Kim, Ki Hwan, Kim, Dong Soo, Cha, Sung Ho, Jo, Dae Sun, Kang, Jin Han
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414646/ https://www.ncbi.nlm.nih.gov/pubmed/25931793 http://dx.doi.org/10.3346/jkms.2015.30.5.612

Ejemplares similares

A randomized study of the immunogenicity and safety of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in comparison with SA14-14-2 Vaccine in children in the Republic of Korea
por: Kim, Dong Soo, et al.
Publicado: (2014)

Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults
por: Khan, Siraj Ahmed, et al.
Publicado: (2016)

Chimeric Japanese Encephalitis Virus SA14/SA14-14-2 Was Virulence Attenuated and Protected the Challenge of Wild-Type Strain SA14
por: Huang, Rong, et al.
Publicado: (2019)

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2021)

The structure differences of Japanese encephalitis virus SA14 and SA14-14-2 E proteins elucidate the virulence attenuation mechanism
por: Liu, Xinyu, et al.
Publicado: (2018)

Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine
por: Wijesinghe, Pushpa Ranjan, et al.
Publicado: (2016)

Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal
por: Upreti, Shyam Raj, et al.
Publicado: (2017)

An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia
por: Hills, Susan L., et al.
Publicado: (2022)

Characteristics of Chimeric West Nile Virus Based on the Japanese Encephalitis Virus SA14-14-2 Backbone
por: Li, Guohua, et al.
Publicado: (2021)

Development and characterization of the replicon system of Japanese encephalitis live vaccine virus SA14-14-2
por: Li, Shi-Hua, et al.
Publicado: (2013)

Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain
por: Yang, Jian, et al.
Publicado: (2017)

Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area
por: Turtle, Lance, et al.
Publicado: (2017)

The Infection of the Japanese Encephalitis Virus SA14-14-2 Strain Induces Lethal Peripheral Inflammatory Responses in IFNAR Deficiency Mice
por: Liu, Juan, et al.
Publicado: (2022)

A Molecularly Cloned, Live-Attenuated Japanese Encephalitis Vaccine SA(14)-14-2 Virus: A Conserved Single Amino Acid in the ij Hairpin of the Viral E Glycoprotein Determines Neurovirulence in Mice
por: Yun, Sang-Im, et al.
Publicado: (2014)

Immune responses and protective effects against Japanese encephalitis induced by a DNA vaccine encoding the prM/E proteins of the attenuated SA14-14-2 strain
por: Zheng, Xiaoyan, et al.
Publicado: (2020)

T cell immunity rather than antibody mediates cross-protection against Zika virus infection conferred by a live attenuated Japanese encephalitis SA14-14-2 vaccine
por: Wang, Ran, et al.
Publicado: (2020)

Immunogenicity and safety of concurrent or sequential administration of live, attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9–12 months of age in the Philippines: A non-inferiority Phase 4 randomized clinical trial
por: Capeding, Maria Rosario, et al.
Publicado: (2020)

Correction: A Molecularly Cloned, Live-Attenuated Japanese Encephalitis Vaccine SA(14)-14-2 Virus: A Conserved Single Amino Acid in the ij Hairpin of the Viral E Glycoprotein Determines Neurovirulence in Mice
Publicado: (2014)

Envelope protein gene based molecular characterization of Japanese encephalitis virus clinical isolates from West Bengal, India: a comparative approach with respect to SA14-14-2 live attenuated vaccine strain
por: Sarkar, Arindam, et al.
Publicado: (2013)

Antibody persistence and immune memory response following primary vaccination and boosting with live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) in Bangladesh: A phase 4 open-label clinical trial
por: Zaman, K., et al.
Publicado: (2022)

The molecular determinants governing the immunogenicity of Japanese encephalitis live attenuated vaccines
por: Li, Yuhua, et al.
Publicado: (2017)

Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC®) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: a phase III, multicenter, double-blinded, randomized trial
por: Yun, Ki Wook, et al.
Publicado: (2015)

Japanese encephalitis virus live attenuated vaccine strains display altered immunogenicity, virulence and genetic diversity
por: Davis, Emily H., et al.
Publicado: (2021)

Recommended immunization schedule for children and adolescents: the Korean Pediatric Society, 2013
por: Jo, Dae Sun, et al.
Publicado: (2013)

Changes in age-specific seroprevalence of Japanese encephalitis virus and impact of Japanese encephalitis vaccine in Korea
por: Kwak, Byung Ok, et al.
Publicado: (2021)

Living the 14/14 Schedule: Qualitative Analysis of the Challenges and Coping Strategies among Families of Offshore Wind Workers
por: Mette, Janika, et al.
Publicado: (2019)

Breast Conservation Therapy Versus Mastectomy in Patients with T1-2N1 Triple-Negative Breast Cancer: Pooled Analysis of KROG 14-18 and 14-23
por: Kim, Kyubo, et al.
Publicado: (2018)

Encephalitis temporally associated with live attenuated Japanese encephalitis vaccine: four case reports
por: Jia, Na, et al.
Publicado: (2011)

Recommended immunization schedule for children and adolescents: Immunization Guideline (8th edition) released by the Korean Pediatric Society in 2015
por: Kim, Jong-Hyun, et al.
Publicado: (2016)

The UK immunisation schedule: changes to vaccine policy and practice in 2013/14
por: Atchison, Christina J, et al.
Publicado: (2015)

Dynamic lipopolysaccharide transfer cascade to TLR4/MD2 complex via LBP and CD14
por: Kim, Soo Jin, et al.
Publicado: (2017)

Japanese Encephalitis, Singapore
por: Koh, Yin-Ling, et al.
Publicado: (2006)

Pharmacokinetic Study of Carboplatin Given on a 5‐Day Intravenous Schedule
por: Ando, Yuichi, et al.
Publicado: (1997)

Corilagin Attenuates the Parkinsonismin Japanese Encephalitis Virus Induced Parkinsonism
por: Yanbing, Ding, et al.
Publicado: (2018)

STUDIES ON THE BIOCHEMICAL, BIOPHYSICAL, AND IMMUNOGENIC PROPERTIES OF JAPANESE B TYPE ENCEPHALITIS VIRUS AND VACCINES
por: Duffy, Carl E., et al.
Publicado: (1945)

Clinical Lecture on Gonorrhœa and Imaginary Spermatorrhœa: Given at St. Mary's Hospital, June 14th, 1861
por: Chambers, Thomas K.
Publicado: (1864)

PS Coordination note: PS Draft schedule: 10-14 October 1961
por: Von Dardel, G
Publicado: (1961)

PS Coordination note: PS Draft schedule: 10-14 october 1961
por: Von Dardel, G
Publicado: (1961)

Post-Marketing Surveillance of Adverse Events Following Vaccination with the Live-Attenuated Japanese Encephalitis Chimeric Virus Vaccine (Imojev(®)) in South Korea, 2015–2019
por: Kim, Hee Soo, et al.
Publicado: (2020)

Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection
por: Lee, Seong tae, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hji55efdv6jrbkj79lps75jmmq